The short version
20 companies supply this market — deep enough that no single failure threatens the supply. The price has jumped 49% in a year, to $0.0043 per unit — sharp rises like this often mean supply is already tightening. One of its named manufacturing plants, B. Braun US Pharmaceutical Manufacturing LLC, failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Historically, drugs in this position went on to a new shortage within 90 days about 1.5% of the time — roughly 10× the typical drug (0.1%).
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.